Stryker ROE 2024

Stryker ROE

0.17

Stryker Dividend yield

0.94 %

Ticker

SYK

ISIN

US8636671013

WKN

864952

In 2024, Stryker's return on equity (ROE) was 0.17, a 19.95% increase from the 0.14 ROE in the previous year.

Stryker Aktienanalyse

What does Stryker do?

Stryker Corp is a global medical technology company based in Kalamazoo, Michigan, USA. It was founded by Dr. Homer Stryker in 1941 and has since become one of the world's leading providers of medical devices, implants, and medical instruments and accessories. The history of Stryker Corp began over 80 years ago with the invention of the "Gipsbruch", a device developed by Dr. Homer Stryker to better treat broken bones. The Gipsbruch marked the beginning of a new era in orthopedics and led to a comprehensive redefinition of patient care. Over the following decades, Stryker Corp developed further life-saving products and solutions that are used worldwide. Stryker Corp offers a wide range of medical devices, implants, instruments, and accessories to support patient care. The company pursues a strategic growth strategy focused on innovation and acquisitions. This includes the development and marketing of new technologies to enhance patients' quality of life. Stryker Corp is divided into three main divisions: Orthopedics, Medical Technology, and Neurotechnology. The Orthopedics division specializes in the development and manufacturing of implants, instruments, and devices for the treatment of musculoskeletal disorders. The Medical Technology division focuses on the development and manufacturing of devices to support surgical procedures and diagnostics in areas such as endoscopy and emergency medicine. The Neurotechnology division specializes in the development and manufacturing of products for the treatment of neurological disorders such as epilepsy, Parkinson's disease, and hydrocephalus. Some of Stryker Corp's well-known products include the Gipsbruch, which has become a standard device in orthopedics. Other significant products include the hip implant system and the knee implant system, which are widely used and successful in many countries worldwide. Another product of Stryker Corp is the Neptune System, a surgical system that enables the safe and effective use of fluids and gases during surgical procedures. Overall, Stryker Corp is a global medical technology company that originated from the invention of the Gipsbruch and is now one of the leading companies in the manufacturing and development of medical devices and instruments. The company pursues a growth strategy based on innovation and acquisitions and has already produced many successful products. The different divisions, Orthopedics, Medical Technology, and Neurotechnology, each focus on different medical disciplines and offer a wide range of products and solutions to support patient care. Stryker ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Stryker's Return on Equity (ROE)

Stryker's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Stryker's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Stryker's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Stryker’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Stryker Stock

What is the ROE (Return on Equity) of Stryker this year?

The ROE of Stryker this year is 0.17 undefined.

How has the Return on Equity (ROE) of Stryker developed compared to the previous year?

The ROE of Stryker has increased by 19.95% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Stryker?

A high ROE indicates that Stryker generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Stryker?

A low ROE can indicate that Stryker is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Stryker affect the company?

A change in ROE (Return on Equity) of Stryker can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Stryker?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Stryker?

Some factors that can influence Stryker's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Stryker pay?

Over the past 12 months, Stryker paid a dividend of 3.05 USD . This corresponds to a dividend yield of about 0.94 %. For the coming 12 months, Stryker is expected to pay a dividend of 3.27 USD.

What is the dividend yield of Stryker?

The current dividend yield of Stryker is 0.94 %.

When does Stryker pay dividends?

Stryker pays a quarterly dividend. This is distributed in the months of July, October, January, April.

How secure is the dividend of Stryker?

Stryker paid dividends every year for the past 34 years.

What is the dividend of Stryker?

For the upcoming 12 months, dividends amounting to 3.27 USD are expected. This corresponds to a dividend yield of 1.01 %.

In which sector is Stryker located?

Stryker is assigned to the 'Health' sector.

Wann musste ich die Aktien von Stryker kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Stryker from 4/30/2024 amounting to 0.8 USD, you needed to have the stock in your portfolio before the ex-date on 3/27/2024.

When did Stryker pay the last dividend?

The last dividend was paid out on 4/30/2024.

What was the dividend of Stryker in the year 2023?

In the year 2023, Stryker distributed 2.835 USD as dividends.

In which currency does Stryker pay out the dividend?

The dividends of Stryker are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Stryker stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von Stryker

Our stock analysis for Stryker Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stryker Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.